Cullen corylifolium (L.) Medik. Seed Extract, an Excellent System For Fabrication of Silver Nanoparticles and Their Multipotency Validation Against Different Mosquito Vectors and Human Cervical Cancer Cell Line
- 25 Downloads
Development of therapeutic drugs for mosquito control and cancer is the need of the hour. This study highlights the fabrication of silver nanoparticles by incubating 45 ml of AgNO3 (0.5 mM) solution with 5 ml of Cullen corylifolium aqueous green seed extract at 60 ± 2 °C, 9 pH for 90 min. Ultraviolet–visible spectroscopy confirmed the synthesis of AgNPs by observing the absorption peak at 422 nm. Crystallographic nature of AgNPs was proved by XRD spectrum. FE-SEM images exhibited that most of AgNPs were spherical in shape with 20–60 nm average size. FT-IR spectrum revealed the existence of secondary metabolites that were involved in the reduction, stabilization and capping of AgNPs. The synthesized AgNPs exhibited the strong bioefficacy against the 3rd instar larvae of Anopheles stephensi (LC50, 6.03; LC90, 10.86 ppm), Aedes aegypti (LC50, 8.29; LC90, 13.75 ppm) and Culex quinquefasciatus (LC50, 16.55; LC90, 36.81 ppm) after 72 h of exposure. The AgNPs also exhibited strong anti-cancer activity having IC50 value 1.129 μg/ml after 24 h. These were proved to be non-toxic against non-target organism and normal cell line. These results suggest that synthesized AgNPs have strong larvicidal and anti-cancer potential and thus can be employed in cancer therapy, targeted drug delivery and drug designing.
KeywordsSeed extract AgNPs Cullen corylifolium Biosynthesis Larvicidal Anti-cancer
Authors are grateful to the Science and Engineering Research Board (SERB), Government of India for the sanction of major Research Project (Grant No. EMR/2016/001673) to VA, and to University of Delhi for providing DST PURSE Grant. Himanshu Saini is grateful to DU-UGC for awarding UGC non-NET fellowship.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.V. Gupta, M. Mittal, and V. Sharma (2014).Oman. Med. J. 29, (2), 142.Google Scholar
- 4.World Health Organization (2017). World malaria report. (accessed on June 30, 2018) Available at: http://www.who.int/malaria/publications/world-malaria-report-2017/en.
- 8.A. Rawani (2017). Int. J. Nanotechnol. Appl. 11, 17–28.Google Scholar
- 14.WHO, Instructions for determining the susceptibility or resistance of mosquito larvae to insecticides (WHO/VBC/81.807, Geneva, 1988).Google Scholar
- 16.Y. R. Saadat, N. Saeidi, S. Z. Vahed, A. Barzegari, and J. Barar (2015). Bioimpacts 5, (1), 25.Google Scholar
- 17.D. J. Finney Probit Analysis, 3d ed (Cambridge University Press, London, 1971), pp. 68–78.Google Scholar
- 21.L. B. Anigol, J. S. Charantimath, and P. M. Gurubasavaraj (2017). Org. Med. Chem. 3, (5), 555–622.Google Scholar
- 34.M. Dubey, S. Bhadauria, and B. S. Kushwah (2009). J. Nanomater. Biostruct. 4, 537–543.Google Scholar
- 42.J. Singh, G. Kaur, P. Kaur, R. Bajaj, and M. Rawat (2016). World. J. Pharm. Pharm. Sci. 7, 730–762.Google Scholar